ATP1A1 and hereditary spastic paraplegia: To date, the phenotype spectrum of de novo ATP1A1 pathogenic variants has included neurodevelopmental disorders (including developmental delay, autism spectrum disorders, and epilepsy), emotional disorders, sleep disorders, and HSP.